Drug Shortage Report for SANDOZ RIZATRIPTAN ODT

Last updated on 2025-04-01 History
Report ID 247620
Drug Identification Number 02351870
Brand name SANDOZ RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN ODT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6ODT
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2025-01-13
Estimated end date 2025-03-28
Actual end date 2025-03-31
Shortage status Resolved
Updated date 2025-04-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-04-01 English Compare
v10 2025-03-31 French Compare
v9 2025-03-31 English Compare
v8 2025-03-17 French Compare
v7 2025-03-17 English Compare
v6 2025-02-10 French Compare
v5 2025-02-10 English Compare
v4 2025-02-03 French Compare
v3 2025-02-03 English Compare
v2 2025-01-13 French Compare
v1 2025-01-13 English Compare

Showing 1 to 11 of 11